<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM956610"><item key="MASS SIZE CM">not specified</item><item key="REANALYSIS OF">GSM637954</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">not specified</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">not specified</item><item key="L">not specified</item><item key="SEX">not specified</item><item key="PROGRESSION-FREE SURVIVAL YEARS">not specified</item><item key="DISEASE STATUS">Reactive lymph node</item><item key="HD NUMBER">not specified</item><item key="SAMPLE TYPE">not specified</item><item key="ANN ARBOR STAGE">not specified</item><item key="HISTOLOGY SUBTYPE">not specified</item><item key="AGE YEARS">not specified</item><item key="ADVANCED">not specified</item><item key="OVERALL SURVIVAL YEARS">not specified</item></item></item><item><item key="GSM9566"><item key="MASS SIZE CM">not specified</item><item key="REANALYSIS OF">GSM637955</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">not specified</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">not specified</item><item key="L">not specified</item><item key="SEX">not specified</item><item key="PROGRESSION-FREE SURVIVAL YEARS">not specified</item><item key="DISEASE STATUS">Reactive lymph node</item><item key="HD NUMBER">not specified</item><item key="SAMPLE TYPE">not specified</item><item key="ANN ARBOR STAGE">not specified</item><item key="HISTOLOGY SUBTYPE">not specified</item><item key="AGE YEARS">not specified</item><item key="ADVANCED">not specified</item><item key="OVERALL SURVIVAL YEARS">not specified</item></item></item><item><item key="GSM956612"><item key="MASS SIZE CM">not specified</item><item key="REANALYSIS OF">GSM637956</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">not specified</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">not specified</item><item key="L">not specified</item><item key="SEX">not specified</item><item key="PROGRESSION-FREE SURVIVAL YEARS">not specified</item><item key="DISEASE STATUS">Reactive lymph node</item><item key="HD NUMBER">not specified</item><item key="SAMPLE TYPE">not specified</item><item key="ANN ARBOR STAGE">not specified</item><item key="HISTOLOGY SUBTYPE">not specified</item><item key="AGE YEARS">not specified</item><item key="ADVANCED">not specified</item><item key="OVERALL SURVIVAL YEARS">not specified</item></item></item><item><item key="GSM956613"><item key="MASS SIZE CM">not specified</item><item key="REANALYSIS OF">GSM637957</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">not specified</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">not specified</item><item key="L">not specified</item><item key="SEX">not specified</item><item key="PROGRESSION-FREE SURVIVAL YEARS">not specified</item><item key="DISEASE STATUS">Reactive lymph node</item><item key="HD NUMBER">not specified</item><item key="SAMPLE TYPE">not specified</item><item key="ANN ARBOR STAGE">not specified</item><item key="HISTOLOGY SUBTYPE">not specified</item><item key="AGE YEARS">not specified</item><item key="ADVANCED">not specified</item><item key="OVERALL SURVIVAL YEARS">not specified</item></item></item><item><item key="GSM956614"><item key="MASS SIZE CM">not specified</item><item key="REANALYSIS OF">GSM637958</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">not specified</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">not specified</item><item key="L">not specified</item><item key="SEX">not specified</item><item key="PROGRESSION-FREE SURVIVAL YEARS">not specified</item><item key="DISEASE STATUS">Reactive lymph node</item><item key="HD NUMBER">not specified</item><item key="SAMPLE TYPE">not specified</item><item key="ANN ARBOR STAGE">not specified</item><item key="HISTOLOGY SUBTYPE">not specified</item><item key="AGE YEARS">not specified</item><item key="ADVANCED">not specified</item><item key="OVERALL SURVIVAL YEARS">not specified</item></item></item><item><item key="GSM956615"><item key="MASS SIZE CM">1</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">8.22</item><item key="WHO PERFORMANCE STATUS">1</item><item key="HASENCLEVER SCORE">not specified</item><item key="L">323</item><item key="SEX">F</item><item key="PROGRESSION-FREE SURVIVAL YEARS">4.28</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD2</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2B</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">25</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">8.22</item></item></item><item><item key="GSM956616"><item key="MASS SIZE CM">11</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">17.66</item><item key="WHO PERFORMANCE STATUS">1</item><item key="HASENCLEVER SCORE">not specified</item><item key="L">221</item><item key="SEX">F</item><item key="PROGRESSION-FREE SURVIVAL YEARS">17.66</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD3</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">3A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">36</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">17.66</item></item></item><item><item key="GSM956617"><item key="MASS SIZE CM">4</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">4.51</item><item key="WHO PERFORMANCE STATUS">1</item><item key="HASENCLEVER SCORE">1</item><item key="L">192</item><item key="SEX">F</item><item key="PROGRESSION-FREE SURVIVAL YEARS">4.51</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD5</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">69</item><item key="ADVANCED">LIM</item><item key="OVERALL SURVIVAL YEARS">4.51</item></item></item><item><item key="GSM956618"><item key="MASS SIZE CM">16</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">0.89</item><item key="WHO PERFORMANCE STATUS">1</item><item key="HASENCLEVER SCORE">3</item><item key="L">224</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">0.00</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD8</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">3B</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">22</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">0.89</item></item></item><item><item key="GSM956619"><item key="MASS SIZE CM">4</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">12.19</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">1</item><item key="L">148</item><item key="SEX">F</item><item key="PROGRESSION-FREE SURVIVAL YEARS">2.02</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD11</item><item key="SAMPLE TYPE">RELAPSE</item><item key="ANN ARBOR STAGE">3A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">38</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">12.19</item></item></item><item><item key="GSM956620"><item key="MASS SIZE CM">11</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">6.14</item><item key="WHO PERFORMANCE STATUS">1</item><item key="HASENCLEVER SCORE">3</item><item key="L">193</item><item key="SEX">F</item><item key="PROGRESSION-FREE SURVIVAL YEARS">0.62</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD15</item><item key="SAMPLE TYPE">RELAPSE</item><item key="ANN ARBOR STAGE">2B</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">28</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">6.14</item></item></item><item><item key="GSM95662"><item key="MASS SIZE CM">4</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">17.64</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">2</item><item key="L">170</item><item key="SEX">F</item><item key="PROGRESSION-FREE SURVIVAL YEARS">0.89</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD20</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">4A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">18</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">17.64</item></item></item><item><item key="GSM956622"><item key="MASS SIZE CM">10</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">18.18</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">2</item><item key="L">116</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">9.00</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD21</item><item key="SAMPLE TYPE">RELAPSE</item><item key="ANN ARBOR STAGE">2B</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">20</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">18.18</item></item></item><item><item key="GSM956623"><item key="MASS SIZE CM">6</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">3.92</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">1</item><item key="L">174</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">0.25</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD24</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">3A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">32</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">3.92</item></item></item><item><item key="GSM956624"><item key="MASS SIZE CM">7</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">5.65</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">2</item><item key="L">163</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">0.00</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD25</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">4A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">36</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">5.65</item></item></item><item><item key="GSM956625"><item key="MASS SIZE CM">11</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">8.47</item><item key="WHO PERFORMANCE STATUS">1</item><item key="HASENCLEVER SCORE">2</item><item key="L">238</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">1.06</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD28</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">12</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">8.47</item></item></item><item><item key="GSM956626"><item key="MASS SIZE CM">7</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">6.53</item><item key="WHO PERFORMANCE STATUS">1</item><item key="HASENCLEVER SCORE">2</item><item key="L">561</item><item key="SEX">F</item><item key="PROGRESSION-FREE SURVIVAL YEARS">6.53</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD30</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">4A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">29</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">6.53</item></item></item><item><item key="GSM956627"><item key="MASS SIZE CM">4</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">4.33</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">1</item><item key="L">137</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">4.33</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD31</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">1A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">36</item><item key="ADVANCED">LIM</item><item key="OVERALL SURVIVAL YEARS">4.33</item></item></item><item><item key="GSM956628"><item key="MASS SIZE CM">6</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">0.48</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">4</item><item key="L">363</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">0.48</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD38</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">3B</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">68</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">0.48</item></item></item><item><item key="GSM956629"><item key="MASS SIZE CM">7</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">4.42</item><item key="WHO PERFORMANCE STATUS">2</item><item key="HASENCLEVER SCORE">1</item><item key="L">192</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">4.42</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD42</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2B</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">42</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">4.42</item></item></item><item><item key="GSM956630"><item key="MASS SIZE CM">4</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">4.55</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">1</item><item key="L">184</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">4.55</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD49</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">17</item><item key="ADVANCED">LIM</item><item key="OVERALL SURVIVAL YEARS">4.55</item></item></item><item><item key="GSM95663"><item key="MASS SIZE CM">3</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">12.55</item><item key="WHO PERFORMANCE STATUS">1</item><item key="HASENCLEVER SCORE">1</item><item key="L">163</item><item key="SEX">F</item><item key="PROGRESSION-FREE SURVIVAL YEARS">12.55</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD54</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">18</item><item key="ADVANCED">LIM</item><item key="OVERALL SURVIVAL YEARS">12.55</item></item></item><item><item key="GSM956632"><item key="MASS SIZE CM">5</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">2.53</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">not specified</item><item key="L">160</item><item key="SEX">F</item><item key="PROGRESSION-FREE SURVIVAL YEARS">2.53</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD56</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">20</item><item key="ADVANCED">LIM</item><item key="OVERALL SURVIVAL YEARS">2.53</item></item></item><item><item key="GSM956633"><item key="MASS SIZE CM">4</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">4.84</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">1</item><item key="L">301</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">4.84</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD57</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">1A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">20</item><item key="ADVANCED">LIM</item><item key="OVERALL SURVIVAL YEARS">4.84</item></item></item><item><item key="GSM956634"><item key="MASS SIZE CM">12</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">20.13</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">not specified</item><item key="L">270</item><item key="SEX">F</item><item key="PROGRESSION-FREE SURVIVAL YEARS">20.13</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD63</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">22</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">20.13</item></item></item><item><item key="GSM956635"><item key="MASS SIZE CM">6</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">20.77</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">1</item><item key="L">nan</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">2.13</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD67</item><item key="SAMPLE TYPE">RELAPSE</item><item key="ANN ARBOR STAGE">3A</item><item key="HISTOLOGY SUBTYPE">MC</item><item key="AGE YEARS">37</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">20.77</item></item></item><item><item key="GSM956636"><item key="MASS SIZE CM">4</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">9.67</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">3</item><item key="L">133</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">9.67</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD68</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2A</item><item key="HISTOLOGY SUBTYPE">MC</item><item key="AGE YEARS">74</item><item key="ADVANCED">LIM</item><item key="OVERALL SURVIVAL YEARS">9.67</item></item></item><item><item key="GSM956637"><item key="MASS SIZE CM">3</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">0.16</item><item key="WHO PERFORMANCE STATUS">2</item><item key="HASENCLEVER SCORE">6</item><item key="L">121</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">0.16</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD70</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">4B</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">71</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">0.16</item></item></item><item><item key="GSM956638"><item key="MASS SIZE CM">2</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">18.74</item><item key="WHO PERFORMANCE STATUS">not specified</item><item key="HASENCLEVER SCORE">2</item><item key="L">1298</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">1.71</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD71</item><item key="SAMPLE TYPE">RELAPSE</item><item key="ANN ARBOR STAGE">3A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">53</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">18.74</item></item></item><item><item key="GSM956639"><item key="MASS SIZE CM">5</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">18.59</item><item key="WHO PERFORMANCE STATUS">1</item><item key="HASENCLEVER SCORE">2</item><item key="L">179</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">1.72</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD78</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">4A</item><item key="HISTOLOGY SUBTYPE">MC</item><item key="AGE YEARS">25</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">18.59</item></item></item><item><item key="GSM956640"><item key="MASS SIZE CM">13</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">8.95</item><item key="WHO PERFORMANCE STATUS">2</item><item key="HASENCLEVER SCORE">4</item><item key="L">454</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">8.95</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD91</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">3B</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">70</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">8.95</item></item></item><item><item key="GSM95664"><item key="MASS SIZE CM">4</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">2.99</item><item key="WHO PERFORMANCE STATUS">1</item><item key="HASENCLEVER SCORE">2</item><item key="L">nan</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">2.99</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD93</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">47</item><item key="ADVANCED">LIM</item><item key="OVERALL SURVIVAL YEARS">2.99</item></item></item><item><item key="GSM956642"><item key="MASS SIZE CM">nan</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">4.20</item><item key="WHO PERFORMANCE STATUS">nan</item><item key="HASENCLEVER SCORE">4</item><item key="L">nan</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">4.20</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD99</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">3A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">67</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">4.20</item></item></item><item><item key="GSM956643"><item key="MASS SIZE CM">10</item><item key="REANALYSIS OF">not specified</item><item key="DISEASE SPECIFIC SURVIVAL YEARS">2.78</item><item key="WHO PERFORMANCE STATUS">2</item><item key="HASENCLEVER SCORE">4</item><item key="L">180</item><item key="SEX">M</item><item key="PROGRESSION-FREE SURVIVAL YEARS">2.78</item><item key="DISEASE STATUS">Hodgkin Lymphoma</item><item key="HD NUMBER">HD107</item><item key="SAMPLE TYPE">DIAGNOSTIC</item><item key="ANN ARBOR STAGE">2A</item><item key="HISTOLOGY SUBTYPE">NS</item><item key="AGE YEARS">52</item><item key="ADVANCED">ADV</item><item key="OVERALL SURVIVAL YEARS">2.78</item></item></item></item><item key="id">4524</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">Hodgkin lymphoma is derived from germinal center / post-germinal center B cells. Gene expression profilies of micodissected Hodkin Reed...</item><item key="geo_gse_id">E-GEOD-39133</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">16</item><item key="sample_count">34</item><item key="tags"><item>hodgkin lymphoma</item><item>lymphoma</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">gene-expression-profiling-of-microdissected-hrs-ce</item><item key="geo_id_plat">E-GEOD-39133_A-AFFY-44</item><item key="name">Gene expression profiling of microdissected HRS cells</item><item key="created">Sep.19, 2014</item><item key="summary">Hodgkin lymphoma is derived from germinal center / post-germinal center B cells. Gene expression profilies of micodissected Hodkin Reed Sternberg cells (n=29) were compared to microdissected germinal centers (n=5)</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-39133</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-39133/samples/</item></data></biogps>
